{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T03:06:16Z","timestamp":1771297576180,"version":"3.50.1"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T00:00:00Z","timestamp":1771200000000},"content-version":"vor","delay-in-days":24,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Surg"],"DOI":"10.1186\/s12893-026-03506-x","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T04:35:50Z","timestamp":1769142950000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The effect of the number of negative lymph nodes removed during surgery on the survival and recurrence rates of patients with breast cancer after surgery"],"prefix":"10.1186","volume":"26","author":[{"given":"Mansour","family":"Bahardoust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Ranjbarpazuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatemeh Naseri","family":"Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Negar","family":"Hashemi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasaman","family":"Tavakoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Kasra","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meisam","family":"Haghmoradi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammadsadra","family":"Shamohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adnan","family":"Tizmaghz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"3","key":"3506_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"3506_CR2","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1038\/s41523-021-00346-1","volume":"7","author":"K El Bairi","year":"2021","unstructured":"El Bairi K, Haynes HR, Blackley E, Fineberg S, Shear J, Turner S, De Freitas JR, Sur D, Amendola LC, Gharib M. The Tale of TILs in breast cancer: a report from the international immuno-oncology biomarker working group. NPJ Breast Cancer. 2021;7(1):150.","journal-title":"NPJ Breast Cancer"},{"key":"3506_CR3","doi-asserted-by":"crossref","unstructured":"Sanaat Z, Dolatkhah R. Epidemiologic profile of breast cancer in Iran: a systematic review and meta-analysis. Clin\u00a0Epidemiol\u00a0Glob Health. 2024;26:101537.","DOI":"10.1016\/j.cegh.2024.101537"},{"key":"3506_CR4","doi-asserted-by":"crossref","unstructured":"Verduzco-Aguirre H, Favorito FM, de Moraes FY, Marta G, Tagle C, Dos Anjos CH, Mattar A, Wilson BE. Twenty years of breast cancer epidemiology and treatment patterns in S\u00e3o Paulo, Brazil\u2014observed versus expected treatment utilization in a retrospective cohort. Lancet Reg Health Am. 2025;47.","DOI":"10.1016\/j.lana.2025.101115"},{"issue":"8","key":"3506_CR5","first-page":"1564","volume":"50","author":"M Alizadeh","year":"2021","unstructured":"Alizadeh M, Ghojazadeh M, Piri R, Mirza-Aghazadeh-Attari M, Mohammadi S, Naghavi-Behzad M. Age at diagnosis of breast cancer in iran: a systematic review and meta-analysis. Iran J Public Health. 2021;50(8):1564.","journal-title":"Iran J Public Health"},{"issue":"1","key":"3506_CR6","doi-asserted-by":"publisher","first-page":"21477","DOI":"10.1038\/s41598-020-78517-6","volume":"10","author":"E Foroozani","year":"2020","unstructured":"Foroozani E, Ghiasvand R, Mohammadianpanah M, Afrashteh S, Bastam D, Kashefi F, Shakarami S, Dianatinasab M. Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in iran: a multi-center study. Sci Rep. 2020;10(1):21477.","journal-title":"Sci Rep"},{"issue":"3","key":"3506_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.clbc.2017.09.005","volume":"18","author":"M Dianatinasab","year":"2018","unstructured":"Dianatinasab M, Mohammadianpanah M, Daneshi N, Zare-Bandamiri M, Rezaeianzadeh A, Fararouei M. Socioeconomic factors, health behavior, and late-stage diagnosis of breast cancer: considering the impact of delay in diagnosis. Clin Breast Cancer. 2018;18(3):239\u201345.","journal-title":"Clin Breast Cancer"},{"key":"3506_CR8","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3389\/fmed.2017.00227","volume":"4","author":"G Turashvili","year":"2017","unstructured":"Turashvili G, Brogi E. Tumor heterogeneity in breast cancer. Front Med. 2017;4:227.","journal-title":"Front Med"},{"issue":"1","key":"3506_CR9","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s10549-018-4879-7","volume":"172","author":"A Saha","year":"2018","unstructured":"Saha A, Harowicz MR, Cain EH, Hall AH, Hwang E-SS, Marks JR, Marcom PK, Mazurowski MA. Intra-tumor molecular heterogeneity in breast cancer: definitions of measures and association with distant recurrence-free survival. Breast Cancer Res Treat. 2018;172(1):123\u201332.","journal-title":"Breast Cancer Res Treat"},{"key":"3506_CR10","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1590\/1806-9282.20211168","volume":"68","author":"F Dal","year":"2022","unstructured":"Dal F, \u00d6kmen H, Ulusan K, \u00c7olak \u015e, Havare SB, Trabulus FDC, Ferlengez E, Sari S. Does focal heterogeneity affect survival in postoperative ipsilateral multifocal and multicentric breast cancers? Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira. 2022;68:405\u201312.","journal-title":"Revista Da Associa\u00e7\u00e3o M\u00e9dica Brasileira"},{"key":"3506_CR11","doi-asserted-by":"publisher","first-page":"103862","DOI":"10.1016\/j.breast.2024.103862","volume":"79","author":"D-D Tang","year":"2025","unstructured":"Tang D-D, Ye Z-J, Liu W-W, Wu J, Tan J-Y, Zhang Y, Xu Q, Xiang Y-B. Survival feature and trend of female breast cancer: a comprehensive review of survival analysis from cancer registration data. Breast. 2025;79:103862.","journal-title":"Breast"},{"issue":"2","key":"3506_CR12","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.artmed.2004.07.002","volume":"34","author":"D Delen","year":"2005","unstructured":"Delen D, Walker G, Kadam A. Predicting breast cancer survivability: a comparison of three data mining methods. Artif Intell Med. 2005;34(2):113\u201327.","journal-title":"Artif Intell Med"},{"issue":"10","key":"3506_CR13","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.1172\/JCI60534","volume":"121","author":"K Polyak","year":"2011","unstructured":"Polyak K. Heterogeneity in breast cancer. J Clin Investig. 2011;121(10):3786\u20138.","journal-title":"J Clin Investig"},{"issue":"32","key":"3506_CR14","doi-asserted-by":"publisher","first-page":"3701","DOI":"10.2217\/fon-2019-0439","volume":"15","author":"X Wang","year":"2019","unstructured":"Wang X, Yin Z, Wang D, Zhang J, Wang S, Zhao J, Wang Q, Zhao L, Zhu L, Xu L, Wang P. Greater negative lymph node count predicts favorable survival of patients with breast cancer in the setting of neoadjuvant chemotherapy and mastectomy. Future Oncol. 2019;15(32):3701\u20139.","journal-title":"Future Oncol"},{"issue":"1","key":"3506_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jss.2009.11.711","volume":"164","author":"AD Brooks","year":"2010","unstructured":"Brooks AD. When it comes to breast cancer staging, lymph node status is King. J Surg Res. 2010;164(1):67\u20138.","journal-title":"J Surg Res"},{"issue":"1","key":"3506_CR16","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10549-015-3451-y","volume":"152","author":"BS Rose","year":"2015","unstructured":"Rose BS, Jiang W, Punglia RS. Effect of lymph node metastasis size on breast cancer-specific and overall survival in women with node-positive breast cancer. Breast Cancer Res Treat. 2015;152(1):209\u201316.","journal-title":"Breast Cancer Res Treat"},{"key":"3506_CR17","unstructured":"Brierley JD, Van Eycken E, Rous B, Giuliani M, editors. TNM classification of malignant tumours. Wiley; 2025."},{"key":"3506_CR18","unstructured":"TNM Classification of Malignant Tumours. 8 edn. Oxford: Wiley; 2017."},{"issue":"13","key":"3506_CR19","doi-asserted-by":"publisher","first-page":"4051","DOI":"10.1245\/s10434-014-3994-x","volume":"21","author":"DM Euhus","year":"2014","unstructured":"Euhus DM. Are axillary lymph nodes still relevant in breast cancer ? Ann Surg Oncol. 2014;21(13):4051\u20133.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"3506_CR20","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1308\/rcsann.2020.0065","volume":"102","author":"T Hubbard","year":"2020","unstructured":"Hubbard T, Ives C. Significance of a positive Sentinel lymph node biopsy in staging for distant metastasis in breast cancer: are current guidelines relevant? Annals Royal Coll Surg Engl. 2020;102(6):429\u201336.","journal-title":"Annals Royal Coll Surg Engl"},{"issue":"1","key":"3506_CR21","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12893-025-02858-0","volume":"25","author":"M Bahardoust","year":"2025","unstructured":"Bahardoust M, Torabi S, Yarahmadi D, kakoienejad MM, Abbasi F, Shamohammadi M, Haghmoradi M, Goodarzy B, Tizmaghz A. Impact of negative lymph node removal on survival in esophageal cancer: a systematic review and meta-analysis. BMC Surg. 2025;25(1):124.","journal-title":"BMC Surg"},{"issue":"9","key":"3506_CR22","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1245\/s10434-014-3665-y","volume":"21","author":"Z Zhu","year":"2014","unstructured":"Zhu Z, Chen H, Yu W, Fu X, Xiang J, Li H, Zhang Y, Sun M, Wei Q, Zhao W. Number of negative lymph nodes is associated with survival in thoracic esophageal squamous cell carcinoma patients undergoing three-field lymphadenectomy. Ann Surg Oncol. 2014;21(9):2857\u201363.","journal-title":"Ann Surg Oncol"},{"issue":"18","key":"3506_CR23","doi-asserted-by":"publisher","first-page":"e42402","DOI":"10.1097\/MD.0000000000042402","volume":"104","author":"M Bahardoust","year":"2025","unstructured":"Bahardoust M, Yarahmadi D, Niroomand B, Rashidi S, Daneshfar F, Haghmoradi M, Goodarzy B, Tizmaghz A. Effect of the number of negative lymph nodes removed on the survival and recurrence rate patients with non-small-cell lung cancer undergoing surgery: a multicenter retrospective cohort study. Medicine. 2025;104(18):e42402.","journal-title":"Medicine"},{"issue":"1","key":"3506_CR24","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1475-2867-13-6","volume":"13","author":"Y Chen","year":"2013","unstructured":"Chen Y, Zhang L, Tian J, Ren X, Hao Q. Combining the negative lymph nodes count with the ratio of positive and removed lymph nodes can better predict the postoperative survival in cervical cancer patients. Cancer Cell Int. 2013;13(1):6.","journal-title":"Cancer Cell Int"},{"key":"3506_CR25","doi-asserted-by":"crossref","unstructured":"He WZ, Xie QK, Hu WM, Kong PF, Yang L, Yang YZ, Jiang C, Yin CX, Qiu HJ, Zhang HZ, Zhang B, Xia LP. An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients. Cancer Manag Res. 2018 Jun 18;10:1597\u20131604.","DOI":"10.2147\/CMAR.S160100"},{"issue":"22","key":"3506_CR26","doi-asserted-by":"publisher","first-page":"3570","DOI":"10.1200\/JCO.2006.06.8866","volume":"24","author":"PM Johnson","year":"2006","unstructured":"Johnson PM, Porter GA, Ricciardi R, Baxter NN. Increasing negative lymph node count is independently associated with improved long-term survival in stage IIIB and IIIC colon cancer. J Clin Oncol. 2006;24(22):3570\u20135.","journal-title":"J Clin Oncol"},{"issue":"1","key":"3506_CR27","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s12885-015-1061-z","volume":"15","author":"S-G Wu","year":"2015","unstructured":"Wu S-G, Sun J-Y, Zhou J, Li F-Y, Lin Q, Lin H-X, Guan X-X, He Z-Y. Number of negative lymph nodes is associated with disease-free survival in patients with breast cancer. BMC Cancer. 2015;15(1):43.","journal-title":"BMC Cancer"},{"issue":"2","key":"3506_CR28","first-page":"844","volume":"5","author":"SG Wu","year":"2015","unstructured":"Wu SG, Wang Y, Zhou J, Sun JY, Li FY, Lin HX, He ZY. Number of negative lymph nodes should be considered for incorporation into staging for breast cancer. Am J Cancer Res. 2015;5(2):844\u201353.","journal-title":"Am J Cancer Res"},{"issue":"11","key":"3506_CR29","first-page":"569","volume":"33","author":"F Gao","year":"2014","unstructured":"Gao F, He N, Wu PH. The number of tumor-free axillary lymph nodes removed as a prognostic parameter for node-negative breast cancer. Chin J Cancer. 2014;33(11):569\u201373.","journal-title":"Chin J Cancer"},{"issue":"12","key":"3506_CR30","doi-asserted-by":"publisher","first-page":"7450","DOI":"10.21037\/tcr-20-2351","volume":"9","author":"H Wu","year":"2020","unstructured":"Wu H, Huang Y. Negative lymph node count is an independent prognostic factor for female patients with node positive breast cancer. Transl Cancer Res. 2020;9(12):7450\u20137.","journal-title":"Transl Cancer Res"},{"issue":"3","key":"3506_CR31","doi-asserted-by":"publisher","first-page":"e0193784","DOI":"10.1371\/journal.pone.0193784","volume":"13","author":"X Zhao","year":"2018","unstructured":"Zhao X, Wei J, Li X, Yang H, Wang P, Cao S. Increasing negative lymph node count predicts favorable OS and DSS in breast cancer with different lymph node-positive subgroups. PLoS ONE. 2018;13(3):e0193784.","journal-title":"PLoS ONE"},{"issue":"2","key":"3506_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.5144\/0256-4947.2005.111","volume":"25","author":"KI Al-Shibli","year":"2005","unstructured":"Al-Shibli KI, Mohammed HA, Mikalsen KS. Sentinel lymph nodes and breast carcinoma: analysis of 70 cases by frozen section. Ann Saudi Med. 2005;25(2):111\u20134.","journal-title":"Ann Saudi Med"},{"issue":"1","key":"3506_CR33","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1186\/s12885-021-08582-1","volume":"21","author":"G Wang","year":"2021","unstructured":"Wang G, Zhang S, Wang M, Liu L, Liu Y, Tang L, Bai H, Zhao H. Prognostic significance of occult lymph node metastases in breast cancer: a meta-analysis. BMC Cancer. 2021;21(1):875.","journal-title":"BMC Cancer"},{"issue":"4","key":"3506_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1245\/ASO.2006.02.020","volume":"13","author":"M Schaapveld","year":"2006","unstructured":"Schaapveld M, de Vries EG, van der Graaf WT, Otter R, de Vries J, Willemse PH. The prognostic effect of the number of histologically examined axillary lymph nodes in breast cancer: stage migration or age association? Ann Surg Oncol. 2006;13(4):465\u201374.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"3506_CR35","first-page":"697","volume":"22","author":"V Vinh-Hung","year":"2003","unstructured":"Vinh-Hung V, Burzykowski T, Cserni G, Voordeckers M, Van De Steene J, Storme G. Functional form of the effect of the numbers of axillary nodes on survival in early breast cancer. Int J Oncol. 2003;22(3):697\u2013704.","journal-title":"Int J Oncol"},{"key":"3506_CR36","doi-asserted-by":"crossref","unstructured":"Alberts E, Wall I, Calado DP, Grigoriadis A. Immune crosstalk between lymph nodes and breast carcinomas, with a focus on B cells. Front Mol Biosci. 2021;8.","DOI":"10.3389\/fmolb.2021.673051"},{"issue":"1","key":"3506_CR37","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12893-023-02154-9","volume":"23","author":"M Bahardoust","year":"2023","unstructured":"Bahardoust M, Kheirabadi M, Donyadideh G, Khaleghian M, Haghmoradi M, Tizmaghz A. Effect of the number of negative lymph nodes removed on the survival and recurrence rate after gastrectomy in patients with gastric cancer: a multicenter retrospective cohort study. BMC Surg. 2023;23(1):246.","journal-title":"BMC Surg"},{"issue":"10","key":"3506_CR38","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1007\/s00262-019-02330-y","volume":"68","author":"J Rotman","year":"2019","unstructured":"Rotman J, Koster BD, Jordanova ES, Heeren AM, de Gruijl TD. Unlocking the therapeutic potential of primary tumor-draining lymph nodes. Cancer Immunol Immunother. 2019;68(10):1681\u20138.","journal-title":"Cancer Immunol Immunother"},{"issue":"1","key":"3506_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s12282-013-0497-8","volume":"21","author":"D Liu","year":"2014","unstructured":"Liu D, Chen Y, Deng M, Xie G, Wang J, Zhang L, Liu Q, Yuan P, Feng X. Lymph node ratio and breast cancer prognosis: a meta-analysis. Breast Cancer. 2014;21(1):1\u20139.","journal-title":"Breast Cancer"},{"issue":"3","key":"3506_CR40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/s10549-015-3559-0","volume":"153","author":"F Petrelli","year":"2015","unstructured":"Petrelli F, Viale G, Cabiddu M, Barni S. Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients. Breast Cancer Res Treat. 2015;153(3):477\u201391.","journal-title":"Breast Cancer Res Treat"},{"issue":"2","key":"3506_CR41","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s12094-024-03563-9","volume":"27","author":"Y-h Kong","year":"2025","unstructured":"Kong Y-h, Huang J-y, Ding Y, Chen S-h, Li Q-s, Xiong Y. The effect of BMI on survival outcome of breast cancer patients: a systematic review and meta-analysis. Clin Transl Oncol. 2025;27(2):403\u201316.","journal-title":"Clin Transl Oncol"},{"key":"3506_CR42","doi-asserted-by":"crossref","unstructured":"Abdul Rahman H, Zaim SNN, Suhaimei US, Jamain AA. Prognostic factors associated with breast cancer-specific survival from 1995 to 2022: a systematic review and meta-analysis of 1,386,663 cases from 30 countries. Diseases. 2024;12(6).","DOI":"10.3390\/diseases12060111"},{"issue":"2","key":"3506_CR43","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.18632\/oncotarget.23086","volume":"9","author":"Q-H Zhan","year":"2017","unstructured":"Zhan Q-H, Fu J-Q, Fu F-M, Zhang J, Wang C. Survival and time to initiation of adjuvant chemotherapy among breast cancer patients: a systematic review and meta-analysis. Oncotarget. 2017;9(2):2739.","journal-title":"Oncotarget"},{"key":"3506_CR44","doi-asserted-by":"crossref","unstructured":"Bahardoust, M., Yarahmadi, D., Rad, F.N. et al. Association of a high versus low number of negative lymph nodes removed with survival and recurrence-free survival after lymph node dissection in breast cancer: a systematic review and meta-analysis of observational studies. Clin Exp Med 26, 88 (2026)","DOI":"10.1007\/s10238-025-01967-7"},{"issue":"4","key":"3506_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1177\/1558944720963944","volume":"17","author":"AJ Forte","year":"2022","unstructured":"Forte AJ, Huayllani MT, Boczar D, Manrique OJ, Lu X, McLaughlin SA, Kung TA. A systematic review of peripheral neuropathies in breast cancer\u2013related lymphedema. HAND. 2022;17(4):668\u201375.","journal-title":"HAND"}],"container-title":["BMC Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12893-026-03506-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12893-026-03506-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T02:02:54Z","timestamp":1771293774000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12893-026-03506-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3506"],"URL":"https:\/\/doi.org\/10.1186\/s12893-026-03506-x","relation":{},"ISSN":["1471-2482"],"issn-type":[{"value":"1471-2482","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"26 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Iran, University of medical science, approved this study. The study protocol was conducted in accordance with the ethical standards outlined in the Declaration of Helsinki. The Ethics Committee\/Institutional Review Board of (Iran University of medical science) waived the need for informed consent. The need for informed consent was waived by the Ethics Committee of Iran University of Medical Sciences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"139"}}